Gabelli Funds LLC Sells 40,200 Shares of The Cooper Companies, Inc. $COO

Posted by on Jul 28th, 2026

Gabelli Funds LLC cut its stake in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 36.1% in the first quarter, HoldingsChannel reports. The institutional investor owned 71,200 shares of the medical device company’s stock after selling 40,200 shares during the quarter. Gabelli Funds LLC’s holdings in Cooper Companies were worth $5,091,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Root Financial Partners LLC grew its position in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. raised its stake in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Cooper Companies during the second quarter valued at $36,000. Cromwell Holdings LLC lifted its holdings in shares of Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 273 shares during the period. Finally, MUFG Securities EMEA plc acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at $42,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO stock opened at $70.29 on Tuesday. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The stock has a market capitalization of $13.71 billion, a PE ratio of 59.57, a PEG ratio of 1.84 and a beta of 0.84. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock’s fifty day moving average is $67.53 and its 200-day moving average is $72.02.

Cooper Companies (NASDAQ:COO – Get Free Report) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on COO. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. Citigroup reaffirmed a “neutral” rating and set a $76.00 price objective (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. Finally, Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $81.85.

Read Our Latest Analysis on COO

About Cooper Companies

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Read More

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.